15.11.2019 • NewsDede WillamsLanxess

Lanxess Sells Organometallics to PMC

Lanxess Sells Organometallics to PMC (c) Lanxess
Lanxess Sells Organometallics to PMC (c) Lanxess

German specialty chemicals company Lanxess has agreed to sell its organometallics business to US chemicals firm PMC Group. Financial terms were not disclosed.

PMC’s European subsidiary will acquire the business, which includes Lanxess’s global organotin catalyst, organotin specialties and intermediates product lines. The deal also includes a toll manufacturing agreement under which Lanxess will continue to manufacture certain products for PMC at its plant in Bergkamen, Germany, after the sale has concluded.

The transaction is scheduled to close by the end of the year, subject to customary conditions.

The acquisition is the second for PMC this year and follows the purchase of Solvay’s hydrocolloid product line in January through wholly owned French subsidiary PMC Ouvrie.  The products are sold to the home and personal care, industrial and coatings markets.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.